Krystal Biotech (KRYS) News Today $149.00 +1.30 (+0.88%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$149.42 +0.41 (+0.28%) As of 09/2/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KRYS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Krystal Biotech to Present at Cantor Global Healthcare Conference 2025September 2 at 9:44 PM | finance.yahoo.comJump Financial LLC Purchases New Stake in Krystal Biotech, Inc. $KRYSSeptember 2 at 4:25 AM | marketbeat.comRaymond James Financial Inc. Lowers Position in Krystal Biotech, Inc. $KRYSSeptember 2 at 3:52 AM | marketbeat.comRafferty Asset Management LLC Sells 3,040 Shares of Krystal Biotech, Inc. $KRYSAugust 31 at 5:22 AM | marketbeat.comNorthern Trust Corp Sells 2,268 Shares of Krystal Biotech, Inc. $KRYSAugust 30, 2025 | marketbeat.comDoes Inhaled KB707’s Progress Signal a New Chapter for Krystal Biotech’s (KRYS) Pipeline Strategy?August 28, 2025 | sg.finance.yahoo.comPrice T Rowe Associates Inc. MD Has $74.08 Million Holdings in Krystal Biotech, Inc. $KRYSAugust 28, 2025 | marketbeat.com1832 Asset Management L.P. Takes $24.52 Million Position in Krystal Biotech, Inc. $KRYSAugust 26, 2025 | marketbeat.com185,550 Shares in Krystal Biotech, Inc. $KRYS Acquired by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comChardan Capital Cuts Krystal Biotech (NASDAQ:KRYS) Price Target to $216.00August 24, 2025 | marketbeat.comKrystal Biotech's (KRYS) Buy Rating Reaffirmed at HC WainwrightAugust 24, 2025 | marketbeat.comAdvantage Alpha Capital Partners LP Buys New Holdings in Krystal Biotech, Inc. $KRYSAugust 24, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Krystal Biotech (NASDAQ:KRYS)August 24, 2025 | americanbankingnews.comAberdeen Group plc Lowers Stake in Krystal Biotech, Inc. $KRYSAugust 23, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 37,336 Shares of Krystal Biotech, Inc. $KRYSAugust 23, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Krystal Biotech Through 10 AnalystsAugust 22, 2025 | benzinga.comKrystal Biotech: A "Strong Buy" Despite KB707 Melanoma Tumor Targeting UpdateAugust 22, 2025 | seekingalpha.comKrystal Biotech price target lowered to $216 from $219 at ChardanAugust 22, 2025 | msn.comConnor Clark & Lunn Investment Management Ltd. Buys New Position in Krystal Biotech, Inc. $KRYSAugust 22, 2025 | marketbeat.comKrystal Biotech says prioritizing inhaled KB707, pauses enrollment in OPAL-1August 22, 2025 | msn.comKrystal Biotech adjusts pipeline to prioritize inhaled antitumor agentAugust 22, 2025 | msn.comKrystal Biotech Provides Development Update on Inhaled KB707 for Non-Small Cell Lung Cancer TreatmentAugust 21, 2025 | quiverquant.comQKrystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung CancerAugust 21, 2025 | globenewswire.comDeutsche Bank AG Has $3.92 Million Stake in Krystal Biotech, Inc. $KRYSAugust 20, 2025 | marketbeat.comInvesco Ltd. Reduces Position in Krystal Biotech, Inc. $KRYSAugust 19, 2025 | marketbeat.comNuveen LLC Makes New Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)August 18, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 7,344 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)August 18, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Lord Abbett & CO. LLCAugust 17, 2025 | marketbeat.comCiti Sticks to Their Hold Rating for Krystal Biotech (KRYS)August 16, 2025 | theglobeandmail.comVanguard Group Inc. Reduces Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)August 16, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of "Buy" by AnalystsAugust 15, 2025 | marketbeat.comPublic Sector Pension Investment Board Raises Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)August 14, 2025 | marketbeat.comShe Built a $4.4B Biotech From One Bold Idea at Age 51August 12, 2025 | msn.comBlair William & Co. IL Has $1.70 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)August 10, 2025 | marketbeat.comHC Wainwright Predicts Reduced Earnings for Krystal BiotechAugust 8, 2025 | marketbeat.comKrystal Biotech Q3 EPS Forecast Decreased by William BlairAugust 8, 2025 | marketbeat.comBeacon Harbor Wealth Advisors Inc. Buys New Position in Krystal Biotech, Inc. (NASDAQ:KRYS)August 8, 2025 | marketbeat.comKrystal Biotech FY2025 EPS Forecast Cut by Cantor FitzgeraldAugust 7, 2025 | marketbeat.comKrystal Biotech FY2025 EPS Forecast Reduced by William BlairAugust 7, 2025 | marketbeat.comLocal biotech co-founder named to Forbes 50 Over 50August 7, 2025 | msn.comKrystal Biotech, Inc. (NASDAQ:KRYS) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comInnovationRx: Trump Escalates Demands That Drug Companies Lower PricesAugust 7, 2025 | forbes.comCitigroup Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $166.00August 6, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from Chardan CapitalAugust 6, 2025 | marketbeat.comKrystal Biotech price target lowered to $182 from $192 at BofAAugust 6, 2025 | finance.yahoo.comJefferies Financial Group Inc. Makes New $757,000 Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)August 6, 2025 | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Sees Strong Trading Volume on Earnings BeatAugust 5, 2025 | marketbeat.comKrystal Biotech Second Quarter 2025 Earnings: Beats ExpectationsAugust 5, 2025 | finance.yahoo.comKrystal Biotech (NASDAQ:KRYS) Announces Quarterly Earnings Results, Beats Expectations By $0.09 EPSAugust 5, 2025 | marketbeat.comEvolutionary Tree Capital Management LLC Has $2.41 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)August 5, 2025 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼1.301.01▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼78▲KRYS Articles Average Week Get the Latest News and Ratings for KRYS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Krystal Biotech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GMAB News VTRS News RDY News ASND News QGEN News MRNA News BBIO News ELAN News VRNA News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRYS Stock Alerts